INQOVI is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Taiho Pharmaceutical Co., Ltd.. The primary component is Cedazuridine; Decitabine.
Product ID | 64842-0727_3ac05368-3848-4904-bab0-0aa2bafbb127 |
NDC | 64842-0727 |
Product Type | Human Prescription Drug |
Proprietary Name | INQOVI |
Generic Name | Cedazuridine And Decitabine |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2020-07-07 |
Marketing Category | NDA / NDA |
Application Number | NDA212576 |
Labeler Name | Taiho Pharmaceutical Co., Ltd. |
Substance Name | CEDAZURIDINE; DECITABINE |
Active Ingredient Strength | 100 mg/1; mg/1 |
Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2020-08-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() INQOVI 79282613 not registered Live/Pending |
Otsuka Pharmaceutical Co., Ltd. 2020-02-12 |
![]() INQOVI 79229519 5527182 Live/Registered |
Otsuka Pharmaceutical Co., Ltd. 2017-12-26 |